All companies
Visit website
RECOMPOSE
OperatingRecompose, PBC
Healthcare
Carbon-sequestering green funeral solution that returns us to the earth
Post-money valuation ⓘ
$78.2M
As of Sep 2023 · from RECOMPOSE Preferred Stock 1 · pre-money + amount raised, not a traded price
Total raised
$2,157,461
Across 1 round since 2023
Latest share price
$4.71
RECOMPOSE Preferred Stock 1 offering price
Financials
FY2020–FY2023 · from SEC filings · hover any figure for its source$108K
−$1.1M
2020
$699K
−$1.5M
2021
$837K
−$3.8M
2022
$1.2M
−$4.4M
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2022
FY2023
Income statement
Revenue
$107,645
$699,470
$836,764
$1,184,114
Cost of goods sold
$4,774
$236,604
$443,897
$428,156
Gross margin
96%
66%
47%
64%
Net income
-$1,138,234
-$1,468,252
-$3,757,981
-$4,381,409
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$4,054,791
$7,482,622
$2,305,867
$2,607,580
Accounts receivable
$324,621
$560,088
$509,073
$745,863
Total assets
$7,596,083
$16,234,910
$24,920,885
$26,404,670
Short-term debt
$108,909
$512,621
$1,018,079
$706,154
Long-term debt
$2,059,104
$5,478,210
$14,067,005
$16,841,762
Total liabilities
$2,168,013
$5,990,831
$15,085,084
$17,547,916
Other
Headcount
—
16
—
17
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$78.2M
post-money
RECOMPOSE Preferred Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $2.2M / $5MInvestors 864Post-money $78.2M
Reg CF annual-report compliance
Not requiredFiled Form C-TR (terminated reporting)
Filed 1 of 4 annual reports (FY2022–FY2025)
864 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 11 filings on EDGARSource: ManualCIK 0001707734Share price $4.71
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.